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Abstract
Background: Protein expression in E. coli is the most commonly used system to produce protein
for structural studies, because it is fast and inexpensive and can produce large quantity of proteins.
However, when proteins from other species such as mammalian are produced in this system,
problems of protein expression and solubility arise [1]. Structural genomics project are currently
investigating proteomics pipelines that would produce sufficient quantities of recombinant proteins
for structural studies of protein complexes. To investigate how the E. coli protein expression
system could be used for this purpose, we purified apoptotic binary protein complexes formed
between members of the Caspase Associated Recruitment Domain (CARD) family.
Results: A combinatorial approach to the generation of protein complexes was performed
between members of the CARD domain protein family that have the ability to form hetero-dimers
between each other. In our method, each gene coding for a specific protein partner is cloned in
pET-28b (Novagen) and PGEX2T (Amersham) expression vectors. All combinations of protein
complexes are then obtained by reconstituting complexes from purified components in native
conditions, after denaturation-renaturation or co-expression. Our study applied to 14 soluble
CARD domain proteins revealed that co-expression studies perform better than native and
denaturation-renaturation methods. In this study, we confirm existing interactions obtained in
vivoin mammalian cells and also predict new interactions.
Conclusion: The simplicity of this screening method could be easily scaled up to identify soluble
protein complexes for structural genomic projects. This study reports informative statistics on the
solubility of human protein complexes expressed in E.coli belonging to the human CARD protein
family.
Background
The aim of structural proteomics is to experimentally
derive the 3-dimensional structure of all proteins in
genomes through determination of the 3D structure of
sufficient members in a protein family such that the
remaining structures can be predicted accurately through
computational approaches [2]. The success rates in studies
so far, mainly applied to prokaryotes, are still low. Effec-
tively, 1 to 5% of structures are solved experimentally
from a few thousand of Open Reading Frame (ORF) tested
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to the fact that many proteins are insoluble when
expressed in a heterologous system or when purified and
concentrated at the levels necessary for crystallization
studies. The success rate is even lower when applied to
eukaryotes, where for example, it was shown recently that
in C. elegans only 20% of the ORF cloned produced solu-
ble recombinant protein suitable for structural studies.
This rate is significantly lower than that of structural
genomics studying prokaryotics ORF [3]. In these studies,
a tremendous amount of effort has been spent to improve
protein solubility by switching the expression system,
changing the fusion tags, replacing the expression host,
generating a new structural variant by modifying the pro-
tein through genetic engineering including mutagenesis
[4] and computational approaches, and finally by per-
forming crystallization studies on a protein orthologs to
the initial protein candidate [2,5]. However, full automa-
tion of these approaches needs to be improved and new
technologies are constantly being implemented in the
pipelines to increase our success rates in structure determi-
nation. An even more challenging and important task for
structural proteomics studies is to determine the 3D struc-
ture of all the protein complexes of an organism. Most
proteins do not work as a monomer, but interact with
other proteins to perform their functions in the form of
stable or transient complexes. In addition, the knowledge
of these interactions is of fundamental importance, since
the genome complexity of an organism is not simply
related to its number of genes but rather is more directly
related to the complexity of its protein-protein interaction
networks. Full automation processes are still difficult
because the proteomics pipeline to obtain sufficient quan-
tities of soluble protein complexes has to allow for the
possibility of different purifications scenarios for each
protein complex. Furthermore, protein complexes are
generally difficult to reconstitute from individual protein
components and usually it is almost impossible to purify
sufficient quantities of in vivo protein complexes for struc-
tural studies. Finally, interactions between proteins in
cells are effectively dynamic with a wide range of affinities.
The half-life of protein complexes is quite diversified from
stable complexes to transient interactions and can be
dependent on post-translation modifications. The post-
translational modification may not be reproduced during
in vitro experiments or are inherently not suitable for crys-
tallization studies since highly stable systems are neces-
sary for successful crystallographic studies [6-8].
Three steps are needed to obtain sufficient protein com-
plex in vitro to perform structural studies of protein com-
plexes from individual components. (i) Produce soluble
protein, (ii) make a soluble complex, and (iii) generate
high-concentration and highly purified protein com-
plexes to tackle the crystallization project. In this study,
we focus on the first step, that of obtaining soluble pro-
tein complexes. A few structural genomics initiatives are
currently trying to develop proteomics pipelines that
includes the production in E.coli of recombinant protein
complexes [9]. We tried to identify an ideal protein family
that could be used for this purpose. It should be a small
soluble domain that can perform simple protein com-
plexes and from which many protein complexes have
been identified in vivo. As a result we choose the human
CARD protein family. This protein family belongs to the
death domain super-family consisting of the Death
Domain (DD), Death Effecter Domain (DED) and the
Pyrin, AIM (Absent-in-melanoma), ASC, Apoptosis-asso-
ciated speck-like protein containing a caspase recruitment
domain CARD, and Death-Domain (DD)-like (PAAD/
DAPIN/PYRIN) domain subfamilies. The CARD domain
family contains 35 members that are involved in apopto-
sis and share a domain of 85 amino-acids folded into a 6
helix bundle. The domain is a recruitment domain that
has the ability to form hetero-dimers between members of
the same family providing a structural framework to com-
plete the apoptotic cascade leading to caspase activation
and cell death. To date, two different structures of death
domain complex have been solved by x-ray crystallogra-
phy represented by the structure of the human CARD
domains of Apoptotic Protein Activating Factor-1 (APAF-
1) with caspase-9[10], and the death domain of Pelle with
Tube in Drosophillia[11]. Structural analysis of these two
different protein complexes revealed different modes of
protein-protein recognition while similar domains are
involved in protein-protein interaction.
In this work, the first step of a structural proteomic project
to obtain soluble protein complexes from the CARD
domain is reported. From 25 CARD proteins cloned and
expressed in E.coli, 14 different CARD soluble proteins
were obtained. Protein purification of CARD recombinant
proteins were performed and binary protein complexes
were reconstituted systematically from purified individual
components under native, denaturation-renaturation
conditions and by co-expressing two different CARD pro-
teins simultaneously in E. coli to identify stable protein-
protein interactions.
Results
Expression and solubility
To study the interaction between CARD-containing pro-
teins, 14 CARD recombinant proteins were subjected to
three different binding assays. First, all recombinant
clones were characterized for their expression and solubil-
ity in E. coli. Comparison of the total cell lysate and solu-
ble protein fractions revealed that most of the CARD
proteins were expressed at medium or high levels (2–5
mg/liter). Only pET constructs (that add a poly-histidine
to the N-terminus of the expressed protein of interest)Page 2 of 9
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the equine herpesvirus-2 E10 gene containing an amino-
terminal caspase recruitment domain (BCL10) and the
apoptotic protein containing a CARD domain (CLAN)
(pET-28b-BCL10 and pET-28b-CLAN) were producing a
recombinant protein expressed at low level (less than 1
mg/ml). Protein expression was induced at two different
temperatures (37°C and 30°C) and two different IPTG
concentrations (1 mM and 0.1 mM) to find the optimal
solubilization conditions.
Three pET-28b-constructs of the, CARD only protein
(COP), NucleOLar protein 3 (NOL3), and the Apoptosis-
associated Speck-like protein containing a CARD (ASC)
(pET-28b-COP, pET-28b-NOL3, and pET-28b-ASC) pro-
duced in E.coli recombinant proteins were insoluble.
Although some improvement of solubility was seen after
induction at 30°C, we classified them as "not soluble"
because of low yield (below 1 mg/L of culture). These
insoluble proteins were purified from E. coli under dena-
turing conditions and then renatured back to the native
state. The status of refolding was confirmed by circular
dichroism (CD) experiments (data not shown).
Protein purification and direct native binding assay
The 14 cloned, CARD-containing proteins were purified
on a larger scale and their optimal solubilization condi-
tions were determined empirically. If insufficient protein
purity (<90%) was obtained after his-tag affinity purifica-
tion, some of the proteins were further subjected to ion-
exchange chromatography. A total of 91 samples were ini-
tially set up for direct binding under native conditions. A
quick way to observe any binding was to run these sam-
ples on a continuous non-denaturing polyacrylamide gel,
along with the individual proteins as a control. Any shift
in the electrophoretic mobility relative to that of the con-
trol lanes would indicate positive binding. This approach
resulted in the identification of one direct binding and 3
indirect bindings (See additional file 1, Figure 1). Only
one sample, run on a non-denaturating polyacrylamide
gel from a mixture of Apaf-1 and caspase-9, showed a
shifted band relative to Apaf-1 and caspase-9 control
bands. In 3 other samples of the apoptotic protein con-
taining a nucleotide binding domain and a CARD domain
(NAC) and ASC, CARD-9 and BCL-10, ASC and BCL-10,
we observed a decrease in the intensity of the stained
bands for the protein mixture sample lane corresponding
to the individual protein, but we did not detect any shifted
band for the protein complex. We suggest that in these
assays binding occurred because an equal amount of pro-
tein was loaded in the control lanes as in the protein mix-
ture sample lanes, but the total charge of the protein
complex is such that the complex cannot migrate into the
gel during the electrophoresis. Consequently, the protein
complex is not detected by the staining procedure. In
addition, the two protein-protein interactions between
NAC and ASC, CARD-9 and BCL-10 were confirmed by
other investigators [12,13] while the binding between
ASC and BCL-10 has not yet been determined experimen-
tally. There may also be additional bindings that were not
detected because of the limited sensitivity of Coomassie
blue staining.
Induced denaturation-renaturation binding assay
To identify any additional bindings, we decided to dena-
ture the protein mixture first, and then refold both pro-
teins in order to obtain the protein complex. This
approach resulted in the identification of a total of 5 bind-
ings including the one observed from the native binding
assay with Apaf-1 and caspase-9 (See additional file 2).
Non- denaturating polyacrylamide gel electrophoresis
revealed bindings within the following proteins: The
Apoptotic Protein Activating Factor-1 (Apaf-1) and cas-
pase-9, NAC and Apaf-1, the Tumor Up-regulated CARD-
containing Antagonist of caspase-Nine (TUCAN) and
Native binding assay between Apaf-1 and Caspase-9 detected by PAGEFigure 1
Native binding assay between Apaf-1 and Caspase-9 
detected by PAGE. Binding reactions were performed 
using an equal amount of putative interacting histidine-tagged 
native recombinant proteins and incubation overnight in the 
binding buffer containing 50 mM Tris, 100 mM NaCl, pH 8.0. 
The binding was analyzed by a continuous Poly-Acrylamide 
Gel Electrophoresis (PAGE) (10%) followed by Coomassie 
Blue staining.Page 3 of 9
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ure 2). NAC and Apaf-1 have been previously shown to
bind to each other by immunoprecipitation [14]. Bind-
ings were also reported for TUCAN and caspase-9 [15],
and NAC and CLAN [16], which is consistent with our
findings. In addition, one additional binding observed
between CLAN and CARD-9 was newly identified.
Co-expression analysis
In this study, the interaction of 14 CARD-containing pro-
teins was investigated by co-expression in E. coli using a
two-vector expression system with two different antibiotic
resistances. The chosen expression vectors were pET-28b
and pGEX-2T (that add a glutathione S-Transferase at the
N-terminus of the expressed protein) with kanamycin and
ampicillin resistances, respectively. Since only the protein
expressed from pET-28b carries an N-terminal histidine-
tag, retention of the other protein on a Ni-NTA affinity
column depends on its interaction with the pET-28b
expressed protein. In order to prevent any possible false
positive bindings, pGEX-2T proteins were expressed alone
and were also subjected to Ni-NTA affinity chromatogra-
phy. In addition, each CARD protein was cloned in both
vectors to perform the assay in both directions. A total of
156 co-expressions were performed and analyzed by SDS-
PAGE. We obtained 12 positive bindings (See additional
file 3). Among them, NAC, CARD-9, and the Receptor-
Interacting Protein (RIP)-Associated protein with a Death
domain (RAIDD) could form homodimers, regardless of
which vector was used in the pull down assay (Figure 3).
All bindings observed in the previous two assays were also
detected. The previously reported binding of CLAN and
ASC [17] was also confirmed. However, there were some
reported bindings that we did not obtain in this study
including: The binding of CLAN and BCL-10 [16] CARD-
9 and BCL-10 [13], TUCAN and the caspase-1 inhibitor
(ICEBERG) [18], TUCAN and COP [18], and COP and
RICK [19]. In addition, some new bindings were observed
between CARD-9 and RAIDD, CARD-9 and CLAN,
RAIDD and NAC, ASC and ICEBERG
In order to determine whether these in vitro bindings from
co-expression studies also occur in mammalian system,
equal amounts of E. coli recombinant proteins were incu-
bated in rabbit reticulocyte lysate (Figure 4), followed by
immuno-precipitation and western blotting. As expected,
we confirmed protein complex formation in the mamma-
lian system among the newly identified protein com-
plexes by co-expression. One interesting observation is
that the co-expression of the pET-28b-ASC and pGEX-2T-
ICEBERG construct, leads to a soluble protein complex,
while the pET-28b-ASC when expressed individually pro-
duced a recombinant protein considered insoluble.
Discussion
In order to develop a low cost, simple and reliable system,
which may be used to generate in vitro sufficient quantity
of protein complexes for protein structure determination,
we compared three in vitro binding assay systems: native
binding assay, denaturation-renaturation binding assay,
and co-expression binding assay. While these three differ-
ent systems can be easily scaled up to generate large quan-
tities of protein complex at very low cost, their accuracy in
reproducing known CARD-CARD interactions described
in the previous literature were quite different (Figure 5).
According to previous studies, seven CARD protein com-
plexes were reported within our 14 CARD domain mem-
bers ([12-17,20]). Co-expression assay reproduced five of
them with the highest accuracy of 71.4%. Induced
denaturation-renaturation binding assay was able to gen-
erate four complexes from seven published complexes
(57%). Native binding assay detected three complexes
from the seven identified complexes with an accuracy of
Denaturation-renaturation binding assay between NAC and APAF-1, TUCAN and CASPASE-9 detected by PAGEFigure 2
Denaturation-renaturation binding assay between 
NAC and APAF-1, TUCAN and CASPASE-9 
detected by PAGE. Continuous PAGE analyses of CARD-
containing proteins. An equal amount of proteins were incu-
bated in a dialysis bag and dialyzed sequentially in a denatura-
tion buffer, renaturation buffer and binding buffer (see 
material and methods). The protein complex formation was 
visualized by non-denaturating PAGE.Page 4 of 9
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fied a total of four new CARD protein complexes. Co-
expression studies identified all four new complexes and
the other two methods identified one complex each. Our
results from rabbit reticulocyte lysate incubation study
indicated that CARD protein complexes obtained
between RAIDD and NAC, ASC and ICEBERG could be
formed in rabbit reticulocyte mammalian system. A pro-
tein-protein interaction detected between CARD9 and
RAIDD was also identified, but the identified proteins had
different sizes compared to the E.coli recombinant pro-
teins not incubated in the rabbit reticulocyte lysate. These
data might suggest that the differences observed in the
electrophoretic mobility of the interacting proteins could
be accounted for by aggregation, post-translational modi-
fication or assisted folding. Such events would occur dur-
ing their incubation in the mammalian lysate. It is not
surprising that the CARD domain of ASC and ICEBERG
could interact with each other in our assay since both
CARD domains have been shown by others to bind to a
common protein procaspase-1. Effectively, recent studies
[21] demonstrated that ICEBERG binds to procaspase-1
through CARD- CARD interaction, which prevented pro-
caspase-1 association and activation with the NF-kappaB-
activating and cell death-inducing kinase RIP2. As a result,
ICEBERG inhibits the processing of procaspase-1 essential
for the activation of caspase-1. In addition, ASC also inter-
acts with the CARD domain of procaspase-1[22]. Func-
tional outcome of this interaction is dependent on the
expression level of ASC in cells, since ASC enhances cas-
pase-1 secretion into the cell culture at low concentration,
but suppresses it at high concentration. Further studies
will need to be performed to assess the functional signifi-
cance of the interaction between ASC and ICEBERG. It is
also quite striking that the newly identified protein com-
plex obtained between NAC [14] and RAIDD [23] are
among two proteins targets of the stress-induced apopto-
sis pathway, but previously shown to be involved at differ-
ent point of the mitochondrial intrinsic pathway. RAIDD
participates in the activation of caspase-2 by forming a
Immunoprecipitation of putative CARD binary complexes obtained from co-expression assayFigure 3
Immunoprecipitation of putative CARD binary complexes obtained from co-expression assay. Protein lysates 
obtained from the co-expressed E. coli putative CARD complexes were immunoprecipitated with anti-6XHis or anti-GST anti-
body. The precipitated protein samples (lane 3) were loaded onto a SDS-PAGE along with the individually-expressed protein 
lysates (lane 1 and 3). The protein samples from the gel were transferred onto Hybond-ECL (Amersham Biosciences). The 
immunoprecipitated protein complexes were detected with anti-GST and anti-6XHis antibody.Page 5 of 9
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Death Domain protein complex (PIDDosome) [24] that
contain PIDD, RAIDD, and caspase-2. On the contrary
NAC increases the processing of caspase-9 by binding to
Apaf-1 in a multiprotein complex named the apoptosome
consisting of apaf-1 and procaspase-9. So far, there is no
evidence or publications to indicate a protein interaction
between the CARD domain of RAIDD and NAC. Further
functional studies need to be performed to assess the sig-
nificance of this protein complex in apoptosis. Co-incuba-
tion between CARD9 and CLAN in a mammalian system
failed to demonstrate interaction between the CARD
domains of these two proteins. The in vitro protein com-
plex formed between the CARD domains of CARD9 and
CLAN in the co-expression assay could be an artificial or a
newly identified complex. Further investigation, such as
co-expression of these two proteins in mammalian sys-
tem, should be performed to confirm these results.
In this study, co-expression binding assay performed the
best compared to the other 2 approaches tested. It was
also the simplest assay system since it did not require prior
purification of the binding partners before complex for-
mation. In addition, we observed that some proteins were
not soluble when expressed alone, but could form a solu-
ble protein complex in co-expression experiments. For
example, the CARD domain of ASC protein is barely sol-
uble when expressed alone in E. coli, but its complex with
the CARD domain of ICEBERG in co-expression assay is
totally soluble.
Both, native binding assay and induced denaturation-
renaturation binding assay were more sensitive to sample
preparation. For the native assay, among most of the pro-
tein pairs tested the binding was not detected even when
both proteins were well folded and stable. This could indi-
cate that the binding conditions needs to be optimized for
Binary complex formation of CARD protein complex in rabbit reticulocyte lysatesF gure 4
Binary complex formation of CARD protein complex in rabbit reticulocyte lysates. Equal amounts of in vitro 
expressed proteins were incubated in rabbit reticulocyte lysates at 4°C for 1 hour. After incubation, protein and complexes 
were immunoprecipitated with anti-6XHis antibody. The precipitated samples (lane 2) together with the individually-expressed 
proteins (lane 1 and 3) were detected by western blot using anti-GST antibody.Page 6 of 9
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tional modifications are necessary for optimal binding.
For the induced denaturation – renaturation binding
assay, since the co-incubated pairs of proteins are denatur-
ated then renaturated in the same conditions to form
complexes, those conditions should be such that some
potential protein complex could not be formed between
some of the pairs tested in this study [25,26]. This may be
the reason why three out of seven published CARD-CARD
complexes could not be reproduced in this assay.
Conclusion
Our experimental results indicate that the co-expression
system is recommended as the first choice for structural
study of protein-protein complexes. This binding assay
system is simple, inexpensive and can be easily automated
for structural proteomics studies.
Methods
Cloning
EST clones encoding CARD domain were searched in the
NCBI database http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi. 14 EST spanning the CARD domain were
found and used as templates for PCR amplification. The
CARD domains were amplified by PCR and cloned into
the expression vector pET or pGEX to obtain the following
CARD-containing proteins: NAC (residues 1373–1473),
TUCAN (residues 341–431), Apaf-1 (residues 1–108),
caspase-9 (residues 1–111), CARD9 (residues 14–100),
BCL10 (residues 1–104), RAIDD (residues 9–95), COP
(residues 1–98), NOL3 (residues 1–97), CLAN (residues
1–87), RICK (residues 417–540), ICEBERG (residues 1–
90), CARD10 (residues 31–117), and ASC (residues 92–
195). The individual CARD domains (except RICK) were
cloned into the Nde1-BamH1 and BamH1-EcoR1 restric-
tion sites of pET-28b (Novagen) and pGEX-2T vectors,
respectively. Since RICK had an internal BamH1 site in its
sequence we cloned it into Nde1-EcoR1 sites of the
pET28b vector.
Protein expression, solubility, and purification
pET-28b clones were transformed into E.coli BL21(DE3)
(Novagen) and grown on petri dishes containing 50 µg/
ml kanamycin. Cultures were grown from single colonies
in 25 ml LB medium supplemented with kanamycin (40
µg/ml) at 37°C. His-tagged proteins were induced at an
OD600 of 0.6 by the addition of IPTG to a final concentra-
tion of 1mM. After an additional 4 hours of growth at
30°C or 37°C, 2x1 mL aliquots of the culture were centri-
fuged to obtain cell pellets (5 min at 13000 rpm). One of
the cell pellets were re-suspended in denaturing buffer
and kept as the whole cell fraction. The other fractions
were re-suspended in native lysis buffer (50 mM
NaH2PO4, 300 mM NaCl, 10 mM imidazole), sonicated
and centrifuged (5 min at 13000 rpm) in Eppendorf
tubes. The resulting supernatant representing the soluble
protein fraction was compared against the whole cell frac-
tion by SDS-PAGE to determine the size, and the relative
expression and solubility levels of each protein.
Binding assay – native condition
For this assay the 14 pET-28b constructs were transformed
into E. coli BL21 (DE3). Transformed cloned were inocu-
lated into a 50 ml LB for overnight preculture. The non-
saturated bacterial cultures were further diluted into 1
Liter of LB medium for protein expression. The cultures
were grown at 37°C with shaking until an A600 of 0.6 was
reached. Protein expression was induced by the addition
of IPTG to a final concentration of 1 mM and the induc-
tion was allowed to take place for an additional 4 hours.
The induced bacteria were collected by centrifugation (20
min at 4000 rpm). Purification was carried out by either
native or denaturing conditions depending on the
solubility status of the individual proteins. For purifica-
tion under native conditions, the cells were resuspended
in 15 ml 50 mM NaH2PO4, 300 mM NaCl, 10 mM imida-
zole, 5 mM β-mercaptoethanol, and 0.1 mM PMSF at pH
8.0. The cells were lysed with a french pressure cell and
centrifuged for 30 min at 4°C at 18,000 rpm. Ni-NTA
superflow (Qiagen) was used in the His-tag purification of
the induced protein. 1 ml 50% Ni-NTA slurry was used to
pack the chromatography column. The purification of
6xHis-tagged protein was performed in this column using
a 10 to 250 mM imidazole gradient. To facilitate the
Venn diagram representing the overlap between the 3 bind-ing assays testedFi ure 5
Venn diagram representing the overlap between the 
3 binding assays tested. N, represent native, CO, co-
expression and DN-RN DeNaturation-ReNaturation assay.Page 7 of 9
(page number not for citation purposes)
Proteome Science 2005, 3:3 http://www.proteomesci.com/content/3/1/3purification process, the columns were centrifuged for 1
min at 4°C at 800 rpm for the washing and elution steps.
The purified proteins were then dialyzed against binding
buffer containing 50 mM Tris, and 100 mM NaCl at pH
8.0. For purification under denaturing conditions, the
cells were re-suspended in 15 ml of 100 mM NaH2PO4, 10
mM Tris-HCl, 8 M urea, pH 8.0. After loading the lysate
onto the column the renaturation was performed using a
linear 6 M – 1 M urea gradient in 50 mM Tris, 100 mM
NaCl, 5% glycerol, 1 mM EGTA, 0.1 mM PMSF, 2 mM
MgCl2, 14.4 mM β-mercaptoethanol, pH 8.0. Elution of
the bound proteins was performed using a pH gradient
from pH 8.0 to pH 4.5. After elution of the re-natured pro-
teins the protein solution were dialyzed against a binding
buffer containing 50 mM Tris, 100 mM NaCl, pH 8.0. An
equal amount of the purified proteins (91 combinations)
were incubated overnight at 4°C and the binding was ana-
lyzed by continuous non-denaturing polyacrylamide gel
electrophoresis (10% PAGE) followed by Coomassie blue
staining.
Binding assay – induced denaturation-renaturation
The purification of the 14 recombinant proteins were per-
formed as described previously. An equal amount of the
purified proteins (91 combinations) were dialyzed in a
micro dialysis bag (100 µL of total volume used) against
8 M urea, 1 mM EGTA, 0.1 mM PMSF, 50 mM Tris, 100
mM NaCl, 14.4 mM β-mercaptoethanol, pH 8.0. The
denatured proteins were then renaturated by dialyzing
against a renaturation buffer containing 2 M urea, 1 mM
EGTA, 0.1 mM PMSF, 50 mM Tris, 100 mM NaCl, 2 mM
MgCl2, 5% glycerol, 14.4 mM β-mercaptoethanol. The
protein complexes were detected by continuous non-
denaturing polyacrylamide gel electrophoresis (10%) fol-
lowed by Coomassie blue staining.
Binding assay – co-expression in E. coli
A mixture of 10 ng of pET-28b and pGEX-2T constructs
(156 combinations) were transformed into E. coli
BL21(DE3) and grown on petri plates containing 40 µg/
ml kanamycin with 50 µg/ml ampicillin. Cells from 5 ml
overnight cultures grown at 37°C were used to inoculate
100 ml LB medium containing 40 µg/ml kanamycin and
50 µg/ml ampicillin. Protein expression was induced at an
OD600 of 0.6 with the addition of 1 mM of IPTG. After an
additional 4 hours of growth at 37°C, the cells were col-
lected by centrifugation (10 min at 4000 rpm). The
induced cells were then re-suspended in 50 mM Tris (pH
8.0), 100 mM NaCl, 5 mM β-mercaptoethanol, 0.1 mM
PMSF and lysis were performed with a french pressure cell.
Cell lysate were centrifuged 30 min at 4°C at 25,000 g. Ni-
NTA superflow (Qiagen) affinity gel was used for the His-
tag purification of the complex. Elution of the proteins
was performed using a 20 to 250 mM imidazole gradient.
After washing extensively, the bound proteins were eluted
in 500 µL aliquots. The Ni-NTA purified co-proteins and
protein complexes were loaded on SDS-PAGE and stained
with silver nitrate.
Binding assay in rabbit reticulocyte lysate
In order to verify if the positive in vitro interactions
obtained by co-expressing both CARD protein partners in
E. coli were also able to form protein complex in a mam-
malian system, equal amounts of the putative interacting
proteins were incubated in 50 µL of Rabbit Reticulocyte
Lysate (Promega) at 4°C for 1 hour.
The co-expressed proteins or protein complexes and the
binding products in Rabbit Reticulocyte Lysate (Promega)
were immunoprecipitated with anti-6xHis or anti-GST
antibody. Protein-protein interactions were detected by
SDS-PAGE, western blotting and anti-GST or anti-6xHIS.
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nucleotide binding domain and a CARD domain, RAIDD:
receptor-interacting protein (RIP)-Associated ICH-1/
CED-3-homologous protein with a Death domain, DD:
Death domain, DED: Death effector domain, PIDD: P53-
Induced protein with a Death Domain, TUCAN: Tumor
Up-regulated CARD-containing Antagonist of caspase-
Nine, BCl10: cellular homolog of the equine herpesvirus-
2 E10 gene containing an amino-terminal caspase recruit-
ment domain, COP: CARD Only Protein, NOL3: NucleO-
Lar protein 3 or Apoptosis Repressor with CARD domain
(ARC), CLAN: apoptotic protein containing a CARD
domain, a Leucine rich repeat domain (LRR) and a
NACHT domain (initially found in the genes NAip, Ciita,
Het-e and Tp1), RICK: RIP-like interacting CLARP kinase,
IPTG: Isopropyl-βD-thiogalactopyranoside, LB: Luria
Broth medium, PMSF: phenylmethylsulfonyl fluoride
SDS-PAGE: Sodium Dodecyl Sulfate Polyacrylamide Gel
Electrophoresis.
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